GE HealthCare Technologies Inc. reported revenue of $5.29B for the period ended 2026-06-30, +5.8% year on year. Net income was $0.56B, a 10.6% net margin on a 41.2% gross margin. The largest revenue line is Sales of products at 65% of the total. Free cash flow for the period was $0.07B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $5.29B | +5.8% |
| Gross profit | $2.18B | — |
| Operating income | $0.74B | — |
| Net income | $0.56B | +15.2% |
| Gross margin | 41.2% | Net margin 10.6% |
| Revenue Q/Q | +3.2% | — |
| Segment | Revenue | Share |
|---|---|---|
| Sales of products | $3.42B | 64.5% |
| Sales of services | $1.88B | 35.5% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $3.12B | 58.8% |
| R&D | $0.32B | 6.1% |
| SG&A | $1.12B | 21.1% |
| Tax & other | $0.18B | 3.4% |
| Item | Amount |
|---|---|
| Operating cash flow | $0.17B |
| Capital expenditure | $0.10B |
| Free cash flow | $0.07B |
| Cash conversion (OCF / net income) | 30% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
GEV ・ GEN ・ GNRC ・ GD ・ GIS ・ GM ・ GPC ・ GILD ・ GPN ・ GL ・ GDDY ・ GS
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies